Home » Reports » Broker Ratings » AstraZeneca plc 19.5% Potential Upside Indicated by Barclays Capital

AstraZeneca plc 19.5% Potential Upside Indicated by Barclays Capital

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OVERWEIGHT’ today by analysts at Barclays Capital. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Barclays Capital have set their target price at 7200 GBX on its stock. This now indicates the analyst believes there is a possible upside of 19.5% from the opening price of 6023 GBX. Over the last 30 and 90 trading days the company share price has increased 115 points and decreased 177 points respectively. The 1 year high stock price is 6540 GBX while the 52 week low is 5110 GBX.

AstraZeneca plc has a 50 day moving average of 6,082.28 GBX and the 200 Day Moving Average price is recorded at 5,991.80. There are currently 1,000,000,000 shares in issue with the average daily volume traded being 2,494,450. Market capitalisation for LON:AZN is £79,308,960,748 GBP.